Viracta Therapeutics, Inc. (VIRX)

USD 0.02

(14.44%)

Gross Profit Summary of Viracta Therapeutics, Inc.

  • Viracta Therapeutics, Inc.'s latest annual gross profit in 2023 was -492 Thousand USD , down -134.29% from previous year.
  • Viracta Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was -96 Thousand USD , up 12.73% from previous quarter.
  • Viracta Therapeutics, Inc. reported a annual gross profit of -210 Thousand USD in annual gross profit 2022, down -17.98% from previous year.
  • Viracta Therapeutics, Inc. reported a annual gross profit of -178 Thousand USD in annual gross profit 2021, down -302.27% from previous year.
  • Viracta Therapeutics, Inc. reported a quarterly gross profit of -96 Thousand USD for 2024 Q2, up 12.73% from previous quarter.
  • Viracta Therapeutics, Inc. reported a quarterly gross profit of -128 Thousand USD for 2023 Q3, down -7.56% from previous quarter.

Annual Gross Profit Chart of Viracta Therapeutics, Inc. (2023 - 2005)

Historical Annual Gross Profit of Viracta Therapeutics, Inc. (2023 - 2005)

Year Gross Profit Gross Profit Growth
2023 -492 Thousand USD -134.29%
2022 -210 Thousand USD -17.98%
2021 -178 Thousand USD -302.27%
2020 88 Thousand USD -95.75%
2019 2.07 Million USD 81.88%
2018 1.13 Million USD 72.69%
2017 660 Thousand USD -73.97%
2016 2.53 Million USD -17.15%
2015 3.06 Million USD -46.62%
2014 5.73 Million USD -27.93%
2013 7.95 Million USD 111.93%
2012 3.75 Million USD -24.92%
2011 5 Million USD 15013.5%
2010 33.08 Thousand USD -99.12%
2009 3.76 Million USD -30.56%
2008 5.41 Million USD -43.94%
2007 9.66 Million USD -29.51%
2006 13.7 Million USD -17.02%
2005 16.52 Million USD 0.0%

Peer Gross Profit Comparison of Viracta Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
America Great Health 168.58 Thousand USD 391.836%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -96.8%
Aridis Pharmaceuticals, Inc. - USD Infinity%
Biora Therapeutics, Inc. -551 Thousand USD 10.708%
Bio-Path Holdings, Inc. -178 Thousand USD -176.404%
Better Therapeutics, Inc. -2.72 Million USD 81.971%
Calithera Biosciences, Inc. -1.38 Million USD 64.477%
Comera Life Sciences Holdings, Inc. 422.71 Thousand USD 216.391%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -22.91 Million USD 97.853%
Eloxx Pharmaceuticals, Inc. - USD Infinity%
Evelo Biosciences, Inc. - USD Infinity%
Evolutionary Genomics, Inc. -1.02 Million USD 51.835%
Finch Therapeutics Group, Inc. -7.09 Million USD 93.063%
Galera Therapeutics, Inc. -259 Thousand USD -89.961%
Innovation1 Biotech Inc. -52.69 Thousand USD -833.622%
Kiromic BioPharma, Inc. -2.79 Million USD 82.403%
Molecular Templates, Inc. 50.39 Million USD 100.976%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -312.423%
NexImmune, Inc. -1.02 Million USD 51.999%
Orgenesis Inc. -5.72 Million USD 91.406%
Panbela Therapeutics, Inc. -25.64 Million USD 98.082%
Point of Care Nano-Technology, Inc. -4601.00 USD -10593.328%
PaxMedica, Inc. Common Stock - USD Infinity%
Scopus BioPharma Inc. - USD Infinity%
Sorrento Therapeutics, Inc. 29.38 Million USD 101.674%
Statera Biopharma, Inc. -488.31 Thousand USD -0.755%
TRACON Pharmaceuticals, Inc. -232 Thousand USD -112.069%
Trevena, Inc. 1.45 Million USD 133.814%
Vaxxinity, Inc. -2.23 Million USD 77.977%
Vaccinex, Inc. -16 Million USD 96.926%
Vicapsys Life Sciences, Inc. - USD Infinity%
ZIVO Bioscience, Inc. 11.61 Thousand USD 4337.726%